 There is conflicting evidence in the literature suggesting that the use of proton pump inhibitors PPIs, andor some statins can interfere with clopidogrel antiplatelet effect and result in adverse cardiovascular outcomes in patients treated with coronary artery stents and dual antiplatelet therapy. 